Study guide

9.3 Rapid-Fire Master Review: Key Timelines, Quantities, Retention Periods & Forms

Mississippi MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Mississippi MPJE Overview

1.1 Mississippi MPJE Format, Logistics & Official Blueprint 1.2 Study Strategy & Federal vs. Mississippi Legal Hierarchy 1.3 Federal & State Regulatory Authorities & Oversight

2 Chapter 2: Mississippi Pharmacy Governance, Board Structure & Licensure

2.1 Mississippi Board of Pharmacy: Structure, Authority & Operations 2.2 Pharmacist Licensure, Examination, Reciprocity & Continuing Education 2.3 Pharmacy Interns, Externs & Preceptor Requirements 2.4 Pharmacy Technicians: Registration, Scope & Supervision Ratios 2.5 Disciplinary Proceedings, Impairment & Current Monitoring

3 Chapter 3: Pharmacist Practice Standards & Prescribing Authority

3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS) 3.2 Prescriptive Authority in Mississippi: Physicians, Mid-Level Practitioners & Out-of-State 3.3 Collaborative Drug Therapy Management (CDTM) & Institutional Protocols 3.4 Patient Counseling, Prospective DUR & OBRA '90 Mandates 3.5 HIPAA, Patient Privacy & Confidentiality of Pharmacy Records

4 Chapter 4: Controlled Substances: Scheduling, Ordering & Security

4.1 Federal & Mississippi Controlled Substance Scheduling 4.2 DEA Registration, Mississippi Permitting & Physical Security 4.3 Schedule II Ordering: Single-Sheet DEA Form 222 & Electronic CSOS 4.4 Controlled Substance Inventories: Mississippi Annual Mandate 4.5 Controlled Substance Disposal (DEA Form 41) & Theft/Loss Reporting Protocols

5 Chapter 5: Dispensing Controlled Substances & Prescription Processing

5.1 Schedule II Prescriptions: Issuance, Emergency Oral Dispensing & Sequential Prescriptions 5.2 Partial Filling of Controlled Substances: CARA, Out-of-Stock & Long-Term Care 5.3 Schedule III–V Prescriptions: Refill Limitations, Authorizations & Expirations 5.4 Prescription Transfers: Federal & Mississippi Requirements 5.5 Corresponding Responsibility, Red Flags & Legitimate Medical Purpose

6 Chapter 6: Mississippi Prescription Monitoring Program & Public Health Mandates

6.1 Mississippi Prescription Monitoring Program (MS PMP Gateway): Mandates & 24-Hour Reporting 6.2 Opioid Prescribing Limits, MME Calculations & Acute Pain Restrictions 6.3 Naloxone Standing Order, Overdose Prevention & Harm Reduction Dispensing 6.4 Behind-the-Counter Sales: Pseudoephedrine & Ephedrine Regulations 6.5 Pharmacist Immunization Authority & Protocol Administration in Mississippi

7 Chapter 7: Pharmacy Operations, Permits & Facilities

7.1 Community Pharmacy Permits, Pharmacist-in-Charge (PIC) Duties & Staffing 7.2 Institutional & Hospital Pharmacy Practice Regulations 7.3 Automated Medication Systems, Remote Dispensing & Telepharmacy 7.4 Non-Resident (Mail-Order) Pharmacies, Licensure & Wholesale Distributors 7.5 Drug Supply Chain Security Act (DSCSA), Track-and-Trace & Product Quarantines

8 Chapter 8: Compounding Standards, Safety & Product Selection

8.1 Non-Sterile Compounding (USP <795>): Categories, Beyond-Use Dating & Quality Assurance 8.2 Sterile Compounding (USP <797>): Cleanrooms, ISO Classifications & Aseptic Protocols 8.3 Hazardous Drug Handling (USP <800>): Engineering Controls, PPE & Spill Protocols 8.4 Generic Drug Substitution, FDA Orange Book & Purple Book Biosimilars 8.5 Repackaging, Unit-Dose Beyond-Use Dating & FDA Drug Recall Classifications

9 Chapter 9: Review, Clinical Scenarios & High-Yield Calculations

9.1 High-Yield Scenario Review: Resolving Complex Federal vs. Mississippi Legal Conflicts 9.2 Pharmacy Law Calculations: DEA Verification, Days Supply, Limits & Ratios 9.3 Rapid-Fire Master Review: Key Timelines, Quantities, Retention Periods & Forms 9.4 Exam Day Strategy, Computer-Adaptive Pacing & Distractor Elimination 9.5 High-Frequency MPJE Pitfalls & Distractor Traps

9.3 Rapid-Fire Master Review: Key Timelines, Quantities, Retention Periods & Forms

Key Takeaways Explain This Topic AI

Keep federal loss timing separate: initial written DEA notice in one business day and completed online Form 106 in 45 days.

Keep Mississippi loss timing separate: immediate Board notice, remaining-stock inventory in 48 hours, and written report with inventory in 15 days.

Personnel and facility anchors include 15 CE hours annually, 3:1 technicians, PIC 20 hours or 50% whichever is less, a biennial community permit, and an annual Article XXV inventory.

Controlled dispensing anchors include C-II six-month fill limit, 48-hour emergency quantity, seven-day follow-up, 30/72/60-day partial-fill pathways, and no controlled transfers.

Current federal standards include DSCSA TI/TS and small-dispenser extension through November 27, 2027, revised USP <795>/<797>, and the two-table NIOSH 2024 list.

Last updated: August 2026

Rapid Review: Current Numbers and Timelines

Numbers are safest when learned as event → deadline → required action , not as isolated flashcards.

Exam administration

  • Event Current rule
  • MPJE testing 120 questions; 2.5 hours

Completion At least 107 questions for a result; 107–119 incurs proportional unanswered-item penalty; fewer than 107 produces no result

  • Result Pass/Fail; no candidate numeric scaled score
  • Retake 30-day wait; no more than five attempts per jurisdiction
  • NABP charges $100 eligibility application + $170 exam purchase
  • Mississippi personnel and permits
  • Topic Current rule
  • Pharmacist CE 15 hours each annual period; at least 2 live and 2 opioid abuse/addiction; PMP registration
  • CE proof after Board request 5 working days
  • Technician ratio 3 technicians per pharmacist
  • Technician renewal Annually by March 31
  • Intern experience 1,600 hours; vacation/postgraduate maximum 50 hours/week
  • PIC presence 20 hours/week or 50% of operating hours, whichever is less
  • Community permit Biennial, ending December 31 of registration period
  • Ordinary discipline notice At least 30 days
  • Summary-suspension hearing Within 20 days after suspension
  • Appeal Within 30 days to chancery court of county of residence
  • Controlled substances
  • Event Current rule
  • Annual inventory On/about May 1, no later than May 15, or another consistent annual period under Article XXV
  • Schedule II prescription No refills; do not fill after 6 months
  • Emergency oral C-II No more than 48-hour supply; signed follow-up within 7 days
  • Patient/prescriber C-II partial Remaining amount within 30 days of issuance
  • Out-of-stock C-II partial Remaining amount within 72 hours of first dispensing
  • Emergency C-II partial Remaining amount within 72 hours after issuance
  • LTCF/terminal C-II partial Remaining amount within 60 days of issuance
  • Schedule III–V No more than 5 full refills and no fill/refill after 6 months
  • Controlled prescription transfer Prohibited by Mississippi Article XV

Eligible nonprescription Schedule V 120 cc/4 fl oz in 72 hours; no more than 2 sales/7 days and 3/30 days; purchaser at least 18

  • Acquisition records 2 years
  • Disposition records 6 years
  • Disposal records 2 years
  • Loss clocks

Federal and Mississippi clocks run together:

DEA: initial written notice within one business day ; online Form 106 within 45 days .

Mississippi Board: immediate notice ; signed remaining-stock inventory within 48 hours ; written report including inventory within 15 days .

PMP and precursor

  • Topic Current rule
  • PMP report Within 24 hours or next business day; zero reports
  • PMP correction Within 7 days

Pharmacist query New/no-prior-six-month customer before Schedule II opiate; at least every 6 months for controlled-substance patient

  • Reporting exclusion Direct administration and dispensing quantity of 48 hours or less
  • Pseudoephedrine Age 18; 3.6 g/day; 7.2 g/30 days; NPLEx
  • Practice and operations
  • Topic Current rule
  • CDTM Non-scheduled drugs; protocol no more than 2 years
  • Naloxone order Current order effective March 2, 2026
  • Automated-system records 2 years; no universal 24-hour override rule

Telepharmacy 15-mile restriction; 1 certified technician with 2 years; supervisor max 2 sites; inspect within 30 days; records 2 years

  • Institutional cabinet Audit at least monthly
  • Emergency kit Restock/reseal within reasonable time
  • Med-pak BUD no more than 90 days
  • Federal quality and supply chain

DSCSA transaction records: 6 years ; current exchange uses TI and TS , not continuing TH.

Small-dispenser enhanced-security exemption: through November 27, 2027 for qualifying dispensers.

USP <795>: aqueous nonpreserved 14 days refrigerated; aqueous preserved 35 days; nonaqueous oral liquid 90 days; other nonaqueous 180 days.

USP <797> Category 1: 12 hours room / 24 hours refrigerated.

NIOSH: current 2024 hazardous-drug list has two tables.

Use

Before answering, say the full pair aloud: “48 hours—Mississippi loss inventory,” not simply “48 hours.” This prevents collision with 48-hour emergency quantity and PMP exclusion.

Collision drill

“Six months” can mean the C-II Mississippi fill deadline, the Schedule III–V fill/refill life, the pharmacist’s recurring PMP query interval, or the lookback that defines a new/no-recent-opioid customer. “Two years” can mean CDTM protocol maximum, certain controlled acquisition and printout records, disposal records, or automated/telepharmacy records. State the event before the number.

Likewise, 48 hours appears in the emergency oral C-II quantity, Mississippi loss inventory, and the PMP reporting exclusion for a quantity of 48 hours or less. The safest memory card reads “loss discovered → remaining-stock inventory within 48 hours,” not “loss → 48 hours” alone. On exam day, reject any option that attaches the correct number to the wrong verb.

Loading diagram... 9.3 Rapid-Fire Master Review: Key Timelines, Quantities, Retention Periods & Forms — Current Rule Map